Jiangsu Jibeier Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Jiangsu Jibeier Pharmaceutical has a total shareholder equity of CN¥2.3B and total debt of CN¥3.1M, which brings its debt-to-equity ratio to 0.1%. Its total assets and total liabilities are CN¥2.5B and CN¥230.8M respectively. Jiangsu Jibeier Pharmaceutical's EBIT is CN¥256.5M making its interest coverage ratio -39. It has cash and short-term investments of CN¥961.0M.
Key information
0.1%
Debt to equity ratio
CN¥3.10m
Debt
| Interest coverage ratio | -39x |
| Cash | CN¥961.01m |
| Equity | CN¥2.26b |
| Total liabilities | CN¥230.79m |
| Total assets | CN¥2.49b |
Recent financial health updates
No updates
Recent updates
Jiangsu Jibeier Pharmaceutical's (SHSE:688566) Solid Earnings May Rest On Weak Foundations
Nov 06
Even With A 38% Surge, Cautious Investors Are Not Rewarding Jiangsu Jibeier Pharmaceutical Co., Ltd.'s (SHSE:688566) Performance Completely
Oct 08Does Jiangsu Jibeier Pharmaceutical (SHSE:688566) Deserve A Spot On Your Watchlist?
Oct 01Jiangsu Jibeier Pharmaceutical Co., Ltd.'s (SHSE:688566) Shares Lagging The Market But So Is The Business
Jul 30Impressive Earnings May Not Tell The Whole Story For Jiangsu Jibeier Pharmaceutical (SHSE:688566)
May 02Financial Position Analysis
Short Term Liabilities: 688566's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥142.3M).
Long Term Liabilities: 688566's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥88.4M).
Debt to Equity History and Analysis
Debt Level: 688566 has more cash than its total debt.
Reducing Debt: 688566's debt to equity ratio has increased from 0% to 0.1% over the past 5 years.
Debt Coverage: 688566's debt is well covered by operating cash flow (7548.9%).
Interest Coverage: 688566 earns more interest than it pays, so coverage of interest payments is not a concern.